On January 21, 2025, the FDA announced a groundbreaking approval that could significantly expand treatment options for individuals suffering from treatment-resistant depression (TRD). Spravato (esketamine), a nasal spray developed by Janssen Pharmaceuticals, has now been approved as a monotherapy, marking a major milestone in psychiatry. Previously, Spravato was only allowed to be prescribed alongside an …
For individuals struggling with treatment-resistant depression or PTSD, Spravato (esketamine) and ketamine therapy offer hope when traditional treatments fall short. But how do you know if one of these innovative therapies is right for you? Below, we take a closer look at how they work and who benefits most to help you make an informed …
In recent years, mental health therapies have progressed in leaps and bounds. For instance, ketamine therapies have offered renewed hope to individuals battling treatment-resistant depression, PTSD, and other mood disorders—providing a pathway toward lasting relief that wasn’t available previously. If you’ve recently been approved for ketamine or Spravato treatment, you may be curious about how …
Spravato is the brand name for the esketamine based nasal spray. Esketamine is similar to ketamine, and Spravato was FDA-approved in 2019 for treatment-resistant major depression as well as suicidal ideation. Since Spravato has been FDA approved for over 5 years now, it’s common to wonder just how much the first legal psychedelic medicine costs. …
Depression affects millions of people worldwide—impacting over 20 million adults and adolescents in the United States alone. While many people respond to conventional mental health treatments, research shows that 10-30% of individuals with depression see little to no improvement. However, a ground-breaking new treatment called Spravato™ (esketamine) offers hope for those who haven’t found success …
Bespoke Treatment focuses on non-medication treatments that work. We are the first boutique center in Southern California to specialize in personalized TMS therapy, Ketamine treatment, and psychiatry.
